Showing results (2081-2090 of 2,376) with videos related to

Sort By:
Pageof 238
American Journal of Respiratory and Critical Care Medicine|August 9, 2022
Extracellular Vesicle-Encapsulated microRNAs as Novel Biomarkers of Lung HealthChristina M Eckhardt, Simone Gambazza, Tessa R Bloomquist, et al.
ESMO Open|October 30, 2025
A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK)K-L Koster, I Colombo, S Hayoz, et al.
Journal of Natural Products|July 9, 2025
Polyoxygenated Stigmastane-Type Steroids from the Whole Plant of Vernonia glabra (Steetz) Vatke (Asteraceae) and Their Antibacterial and Antioxidant ActivitiesVoutro Kana Takeuneu, Paul Eckhardt, Borice Tapondjou Tsafack, et al.
The British Journal of Social Psychology|July 23, 2025
The 'twin pandemics'? modelling and predicting the trajectories of IPV perpetration during the COVID-19 pandemic in AustraliaGery C Karantzas, Daniel A Romano, Susan Chesterman, et al.
Oncology (Williston Park, N.Y.)|September 3, 1998
Alternative dosing schedules for irinotecanM L Rothenberg, J G Kuhn, L J Schaaf, et al.
Frontiers in Pharmacology|March 26, 2013
Tumor P-Glycoprotein Correlates with Efficacy of PF-3758309 in in vitro and in vivo Models of Colorectal CancerErica Lynn Bradshaw-Pierce, Todd M Pitts, Aik-Choon Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2010
Development of an integrated genomic classifier for a novel agent in colorectal cancer: approach to individualized therapy in early developmentTodd M Pitts, Aik Choon Tan, Gillian N Kulikowski, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 28, 2007
Male germ cell expression of the PAS domain kinase PASKIN and its novel target eukaryotic translation elongation factor eEF1A1Katrin Eckhardt, Juliane Troger, Jana Reissmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Phase I and pharmacokinetic study of the differentiating agent vesnarinone in combination with gemcitabine in patients with advanced cancerA Patnaik, E K Rowinsky, B K Tammara, et al.
Cancers|March 25, 2020
Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast CancerTodd M Pitts, Dennis M Simmons, Stacey M Bagby, et al.
Pageof 238